Vaccine and antibody-directed T cell tumour immunotherapy.


Clearer evidence for immune surveillance in malignancy and the identification of many new tumour-associated antigens (TAAs) have driven novel vaccine and antibody-targeted responses for therapy in cancer. The exploitation of active immunisation may be particularly favourable for TAA where tolerance is incomplete but passive immunisation may offer an… (More)


Cite this paper

@article{Dermime2004VaccineAA, title={Vaccine and antibody-directed T cell tumour immunotherapy.}, author={Said Dermime and David Edward Gilham and David M. Shaw and E Joyce Davidson and E M M{\'e}ziane and Anne C. Armstrong and Robert Edward Hawkins and Peter Stern}, journal={Biochimica et biophysica acta}, year={2004}, volume={1704 1}, pages={11-35} }